Here is your NEWS-Line for Pharmacists eNewsletter. For the latest news, jobs, education and blogs, bookmark our news page and job board or to take us everywhere with you, save this link to your phone. Also, enjoy the latest issue of NEWS-Line magazine, always free.
Lilly Cuts Insulin Prices by 70% and Caps Patient Insulin Out-of-Pocket Costs at $35 Per Month
Eli Lilly and Company (NYSE: LLY) announced price reductions of 70% for its most commonly prescribed insulins and an expansion of its Insulin Value Program that caps patient out-of-pocket costs at $35 or less per month. Lilly is taking these actions to make it easier to access Lilly insulin and help Americans who may have difficulty navigating a complex healthcare system that may keep them from getting affordable insulin.
Lilly is reducing the list price of insulins by:
Cutting the list price of its non-branded insulin, Insulin Lispro Injection 100 units/mL, to $25 a vial. Effective May 1, 2023, it will be the lowest list-priced mealtime insulin available, and less than the price of a Humalog® vial in 1999.
Cutting the list price of Humalog® (insulin lispro injection) 100 units/mL1, Lilly's most commonly prescribed insulin, and Humulin® (insulin human) injection 100 units/mL2 by 70%,
Read Full Article
Defensive Beliefs Likely Keep People From Taking At-Home Stool Tests That Screen For Colorectal Cancer
Colorectal cancer is one of the most treatable cancers, especially if it is detected early; however, many people do not undergo recommended screening, even despite the availability of at-home stool fecal immunochemical test (FIT) kits. New research published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society, reveals that people who react defensively to the invitation to get screened are less likely to take part.
For the study, Nicholas Clarke, PhD, of Dublin City University in Ireland, surveyed individuals in Dublin who had been invited to participate in a FIT screening program in 2008–2012. Questionnaires were mailed in September 2015 to all individuals who were invited to participate (over two screening rounds) but had declined and a random sample of individuals who had participated. Following two reminders, questionnaires were completed by 1,988 peopl
Read Full Article
Heart Rhythm Disorders: What You Need to Know
Heart rhythm disorders like atrial fibrillation and sudden cardiac arrest have made headlines in recent months, prompting many to learn more about how the heart beats.
It is an exciting time in the field of cardiac electrophysiology, with many treatment options newly available to patients and many more on the horizon," said Michael Shehata, MD, a cardiac electrophysiologist and director of the Interventional Electrophysiology Laboratory in the Smidt Heart Institute at Cedars-Sinai. "The field is unique in that we treat patients across the age spectrum with myriad conditions, many of which we can cure and treat completely."
Shehata says the most common heart rhythm disorders he treats are atrial fibrillation--an irregular, often rapid, heart rate that causes poor blood flow and is expected to affect 12.1 million Americans by 2030--and ventricular arrhythmia, an abnormal heart rhythm.
Read Full Article
Lingering Symptoms Common After COVID Hospitalization
About half of adults treated at hospitals for COVID-19 have experienced lingering symptoms, financial difficulties, or physical limitations months after being discharged, according to a National Institutes of Health-supported study published in JAMA Network Open.
After six months, more than 7 in 10 adults surveyed in the study experienced cardiopulmonary problems, such as coughing, rapid or irregular heartbeat, and breathlessness, while about half had fatigue or physical limitations – all symptoms associated with long COVID. Additionally, more than half of the adults said they faced financial challenges.
The findings came from the PETAL Network's Biology and Longitudinal Epidemiology: COVID-19 Observational (BLUE CORAL) study, which is supported by the National Heart, Lung, and Blood Institute (NHLBI), part of NIH.
“My clinic patients often want to know how soon they’ll get back to th